ES2177533T3 - Compuestos analogos a oligonucleotidos derivatizados en 3', con agrupaciones no nucleotidicas, su preparacion y utilizacion. - Google Patents
Compuestos analogos a oligonucleotidos derivatizados en 3', con agrupaciones no nucleotidicas, su preparacion y utilizacion.Info
- Publication number
- ES2177533T3 ES2177533T3 ES93100893T ES93100893T ES2177533T3 ES 2177533 T3 ES2177533 T3 ES 2177533T3 ES 93100893 T ES93100893 T ES 93100893T ES 93100893 T ES93100893 T ES 93100893T ES 2177533 T3 ES2177533 T3 ES 2177533T3
- Authority
- ES
- Spain
- Prior art keywords
- oligonucleotidos
- nucleotidic
- derivatized
- clusters
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 2
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Graft Or Block Polymers (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
ANALOGOS A LOS OLIGONUCLEOTIDOS 2'' DERIVADOS, CON AGRUPACIONES NO NUCLEOTIDAS, SU OBTENCION Y UTILIZACION. LA PRESENTE INVENCION CONCIERNE A NUEVOS ANALOGOS A LOS OLIGONUCLEOTIDOS, CON PROPIEDADES VALIOSAS FISICAS, BIOLOGICAS Y FARMACOLOGICAS, ASI COMO UN PROCEDIMIENTO PARA SU OBTENCION.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4201663 | 1992-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2177533T3 true ES2177533T3 (es) | 2002-12-16 |
Family
ID=6450031
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES93100893T Expired - Lifetime ES2177533T3 (es) | 1992-01-22 | 1993-01-21 | Compuestos analogos a oligonucleotidos derivatizados en 3', con agrupaciones no nucleotidicas, su preparacion y utilizacion. |
| ES01116471T Expired - Lifetime ES2250268T3 (es) | 1992-01-22 | 1993-01-21 | Analogos de oligonucleotidos 3'-derivatizados con agrupaciones no nucleotidicas, su preparacion y utilizacion. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01116471T Expired - Lifetime ES2250268T3 (es) | 1992-01-22 | 1993-01-21 | Analogos de oligonucleotidos 3'-derivatizados con agrupaciones no nucleotidicas, su preparacion y utilizacion. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5646261A (es) |
| EP (2) | EP0552767B1 (es) |
| JP (1) | JP3676388B2 (es) |
| KR (1) | KR100273824B1 (es) |
| AT (2) | ATE217881T1 (es) |
| AU (1) | AU657191B2 (es) |
| CA (1) | CA2087817C (es) |
| DE (2) | DE59310380D1 (es) |
| DK (2) | DK1142902T3 (es) |
| ES (2) | ES2177533T3 (es) |
| FI (1) | FI115215B (es) |
| HU (1) | HUT63172A (es) |
| IL (1) | IL104460A (es) |
| NO (1) | NO308609B1 (es) |
| NZ (1) | NZ245721A (es) |
| PL (1) | PL172245B1 (es) |
| PT (1) | PT552767E (es) |
| ZA (1) | ZA93423B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2966849B2 (ja) * | 1987-12-03 | 1999-10-25 | 三井化学株式会社 | 黄色系昇華転写用色材 |
| ATE151773T1 (de) * | 1992-09-24 | 1997-05-15 | Hoechst Ag | Oligoribonucleotid- und ribozym-analoga mit terminalen 3'-3'-bzw.5'-5'-verknüpfungen |
| EP0602524A1 (de) * | 1992-12-15 | 1994-06-22 | Hoechst Aktiengesellschaft | Chemilumineszenzmarkierte Gensonden und ihre Verwendung in Gensondentesten |
| CA2114355A1 (en) * | 1993-01-29 | 1994-07-30 | Hidehiko Furukawa | Modified oligodeoxyribonucleotides, their preparation and their therapeutic use |
| US5532130A (en) * | 1993-07-20 | 1996-07-02 | Dyad Pharmaceutical Corporation | Methods and compositions for sequence-specific hybridization of RNA by 2'-5' oligonucleotides |
| DE4408528A1 (de) * | 1994-03-14 | 1995-09-28 | Hoechst Ag | Peptid-Oligonucleotid-Derivate, deren Herstellung und Verwendung |
| US6919441B2 (en) | 1994-03-14 | 2005-07-19 | Aventis Pharma Deutschland Gmbh | Polyamide-oligonucleotide derivatives, their preparation and use |
| US6358689B1 (en) * | 1994-05-11 | 2002-03-19 | Boston University | Detection of markers in nascent proteins |
| DE4418691A1 (de) * | 1994-05-28 | 1996-02-22 | Boehringer Mannheim Gmbh | 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer |
| KR970703357A (ko) | 1994-06-01 | 1997-07-03 | 다알렌 반스톤 | 병원체-저해제로서의, 측쇄를 가지는 올리고누클레오티드(branched oligonu-cleotides as pathogen-inhibitory agents) |
| US5696248A (en) * | 1994-06-15 | 1997-12-09 | Hoechst Aktiengesellschaft | 3'-modified oligonucleotide derivatives |
| US6326487B1 (en) | 1995-06-05 | 2001-12-04 | Aventis Pharma Deutschland Gmbh | 3 modified oligonucleotide derivatives |
| US6331617B1 (en) | 1996-03-21 | 2001-12-18 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
| US6274313B1 (en) | 1996-03-21 | 2001-08-14 | Pioneer-Hybrid International, Inc. | Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use |
| US6121437A (en) | 1999-03-16 | 2000-09-19 | Isis Pharmaceuticals, Inc. | Phosphate and thiophosphate protecting groups |
| US20040082774A1 (en) * | 1999-03-16 | 2004-04-29 | Guzaev Andrei P. | Novel phosphate and thiophosphate protecting groups |
| US20040023367A1 (en) * | 2002-07-31 | 2004-02-05 | Affymetrix, Inc. | Method of photolithographic production of polymer arrays |
| US8084589B2 (en) * | 2007-08-31 | 2011-12-27 | University Of Massachusetts | Phosphoramidite nucleoside analogs |
| KR20130136983A (ko) * | 2010-09-24 | 2013-12-13 | 말린크로트 엘엘씨 | 치료 및/또는 진단용 나노담체의 목표화를 위한 압타머 접합체 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3239888A1 (de) * | 1982-10-28 | 1984-05-03 | Hubert Prof. Dr. 2000 Hamburg Köster | Verfahren zur herstellung von oligonucleosidphosphonaten |
| US4739044A (en) * | 1985-06-13 | 1988-04-19 | Amgen | Method for derivitization of polynucleotides |
| US4950745A (en) * | 1986-10-30 | 1990-08-21 | Daicel Chemical Industries, Ltd. | Process for synthesis of oligonucleotides and compound for forming polymeric protecting group |
| US4816571A (en) * | 1987-06-04 | 1989-03-28 | Applied Biosystems, Inc. | Chemical capping by phosphitylation during oligonucleotide synthesis |
| US5216141A (en) * | 1988-06-06 | 1993-06-01 | Benner Steven A | Oligonucleotide analogs containing sulfur linkages |
| US5399676A (en) * | 1989-10-23 | 1995-03-21 | Gilead Sciences | Oligonucleotides with inverted polarity |
| EP0497875B1 (en) * | 1989-10-24 | 2000-03-22 | Isis Pharmaceuticals, Inc. | 2' modified oligonucleotides |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| GB9021625D0 (en) * | 1990-10-04 | 1990-11-21 | Ici Plc | Synthesis of oligonucleotides |
| NZ245720A (en) * | 1992-01-22 | 1995-12-21 | Hoechst Ag | Oligonucleotide analogues; use as gene expression inhibitor or dna probe |
-
1993
- 1993-01-19 US US08/005,283 patent/US5646261A/en not_active Expired - Lifetime
- 1993-01-20 IL IL10446093A patent/IL104460A/xx not_active IP Right Cessation
- 1993-01-20 NZ NZ245721A patent/NZ245721A/en not_active IP Right Cessation
- 1993-01-20 KR KR1019930000676A patent/KR100273824B1/ko not_active Expired - Lifetime
- 1993-01-20 FI FI930221A patent/FI115215B/fi not_active IP Right Cessation
- 1993-01-21 HU HU9300161A patent/HUT63172A/hu unknown
- 1993-01-21 NO NO930200A patent/NO308609B1/no not_active IP Right Cessation
- 1993-01-21 AU AU31911/93A patent/AU657191B2/en not_active Expired
- 1993-01-21 DE DE59310380T patent/DE59310380D1/de not_active Expired - Lifetime
- 1993-01-21 ES ES93100893T patent/ES2177533T3/es not_active Expired - Lifetime
- 1993-01-21 EP EP93100893A patent/EP0552767B1/de not_active Expired - Lifetime
- 1993-01-21 AT AT93100893T patent/ATE217881T1/de active
- 1993-01-21 DK DK01116471T patent/DK1142902T3/da active
- 1993-01-21 ES ES01116471T patent/ES2250268T3/es not_active Expired - Lifetime
- 1993-01-21 EP EP01116471A patent/EP1142902B1/de not_active Expired - Lifetime
- 1993-01-21 PT PT93100893T patent/PT552767E/pt unknown
- 1993-01-21 AT AT01116471T patent/ATE307821T1/de active
- 1993-01-21 DE DE59310287T patent/DE59310287D1/de not_active Expired - Lifetime
- 1993-01-21 DK DK93100893T patent/DK0552767T3/da active
- 1993-01-21 JP JP00825693A patent/JP3676388B2/ja not_active Expired - Lifetime
- 1993-01-21 ZA ZA93423A patent/ZA93423B/xx unknown
- 1993-01-21 CA CA2087817A patent/CA2087817C/en not_active Expired - Lifetime
- 1993-01-22 PL PL93297516A patent/PL172245B1/pl unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2177533T3 (es) | Compuestos analogos a oligonucleotidos derivatizados en 3', con agrupaciones no nucleotidicas, su preparacion y utilizacion. | |
| ES2179351T3 (es) | Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores. | |
| ES2086313T3 (es) | Nuevos derivados de xantina con efecto antagonista de adenosina. | |
| NO902319L (no) | Fremgangsmaate for aa bestemme egenskaper vedroerende stroemningsdynamikk for flerfasestroemning. | |
| UY26495A1 (es) | " derivados de tiazolilamida" | |
| AR240911A1 (es) | "eteres acetilacetoxialquil-alilicos, su obtencion, polimero vinilico con grupos acetilacetoxi, procedimiento para su preparacion y agente obtenido a partir de el". | |
| ES2016957B3 (es) | Procedimiento para la obtencion de n,n'-diarilreas. | |
| ES2143666T3 (es) | P-amidinobencilamidas dipeptidicas con restos sulfonilo, o bien aminosulfonilo n-terminales. | |
| CO4700524A1 (es) | 2-(2-n-alcoxifenil)-purin-6-onas 9 sustituidas | |
| ES2059457T3 (es) | Utilizacion de bezafibrato para el tratamiento de la diabetes. | |
| ATE63904T1 (de) | Azolderivate, geeignet zur bekaempfung von pflanzen-krankheiten. | |
| IT7828098A0 (it) | Processo per la preparazione di granulati dotati di attivita'biologica. | |
| ES2074599T3 (es) | Procedimiento para preparar ciclobutanos sustituidos. | |
| MX9302313A (es) | Procedimiento para la obtencion de hexafluorclorobutenos. | |
| ES2098263T3 (es) | 8-alfa-acilamino-ergolinas, su preparacion y su utilizacion como medicamentos. | |
| ES2130805T3 (es) | Utilizacion de esmectitas acidas por naturaleza para la eliminacion de olefinas a partir de compuestos aromaticos o mezclas de compuestos aromaticos. | |
| ES2083427T3 (es) | Procedimiento para fabricar 2-oxindol-1-carboxamidas. | |
| AR243607A1 (es) | Un procedimiento para la produccion de des(64,65)proinsulina humana. | |
| ES2014290B3 (es) | Uso de acidos 7-cloroquinolina, 8-carbono para influir en el desarrollo de plantas de cultivo. | |
| ES2018747A6 (es) | Monofilamento sintetico perfumado a base de homo- o co-poliamidas y procedimiento de fabricacion. | |
| ES2097857T3 (es) | Canillas recubiertas, un procedimiento para su fabricacion y su uso en el procesamiento de fibras de vidrio. | |
| ES2067108T3 (es) | 4-amino-3-hidroxi-ftalida, asi como un procedimiento para su preparacion. | |
| ES2043896T3 (es) | Procedimiento para la preparacion de derivados de tetrahidropiridina. | |
| ES2165512T3 (es) | Feniluracilos substituidos. | |
| DE3560633D1 (de) | Fenoldopam 4', 8-bis-hydrogen sulfates |